A Study Comparing Topical Skin Adhesive or Sutures for Closure Due to Episiotomy or Perineal Tears Following Childbirth

NCT ID: NCT00196508

Last Updated: 2007-10-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

118 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-04-30

Study Completion Date

2006-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a randomized controlled trial and multi-centered study with a 2-arm design. The treatment group will receive topical skin adhesive for skin closure of their wound and the control will receive sutures. Subjects will be assessed at follow-up visits. Patients are required to maintain a diary postpartum.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Episiotomy Perineal Tear

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Childbirth

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

High Viscosity DERMABOND

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient is at least 18 years of age.
* Patient has an episiotomy incision or perineal tear resulting from a vaginal delivery.
* Patient agrees to participate in the follow-up schedule of assessments and completion of a daily diary.
* Patient has signed the informed consent form.

Exclusion Criteria

* Patient has peripheral vascular disease.
* Patient has insulin dependent diabetes mellitus.
* Patient has a blood clotting disorder that requires therapy.
* Patient has a personal or family history of keloid formation or hypertrophy.
* Patient has a known allergy to cyanoacrylates or formaldehyde.
* Patient has impaired wound healing by history. Patient is a chronic steroid user.
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ethicon, Inc.

INDUSTRY

Sponsor Role lead

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bessemer, Alabama, United States

Site Status

Phoenix OB-GYN Associates

Moorestown, New Jersey, United States

Site Status

McDonald Murrmann Women's Clinic

Memphis, Tennessee, United States

Site Status

Tidewater Physicians for Women

Norfolk, Virginia, United States

Site Status

Virginia Beach Obstetrics & Gynecology

Virginia Beach, Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

200-04-001

Identifier Type: -

Identifier Source: org_study_id